The objective of this study was to assess typical early-onset complications following
ischemic stroke in a large, hospital-based cohort to provide clinical data for future …

Background The contribution of various risk factors to the burden of stroke worldwide is
unknown, particularly in countries of low and middle income. We aimed to establish the …

Background Stroke is a leading cause of death and disability, especially in low-income and
middle-income countries. We sought to quantify the importance of potentially modifiable risk …

Aims The preferred antithrombotic strategy for secondary prevention in patients with
cryptogenic stroke (CS) and patent foramen ovale (PFO) is unknown. We pooled multiple …

Background and Purpose—Data on risk factors for etiologic subtypes of ischemic stroke are
still scant. The aim of this study was to characterize stroke subtypes regarding risk factor …

Background Trials of patent foramen ovale (PFO) closure to prevent recurrent stroke have
been inconclusive. We investigated whether patients with cryptogenic stroke and …

Objective: To perform a systematic review and meta-analysis of studies reporting recurrent
intracranial hemorrhage (ICH) and ischemic stroke (IS) in ICH survivors with atrial fibrillation …

Background Treatment strategies for acute basilar artery occlusion (BAO) are based on case
series and data that have been extrapolated from stroke intervention trials in other …

Background and Purpose—Numerous preclinical findings and a clinical pilot study suggest
that recombinant human erythropoietin (EPO) provides neuroprotection that may be …

Objective: We aimed to create an index to stratify cryptogenic stroke (CS) patients with
patent foramen ovale (PFO) by their likelihood that the stroke was related to their PFO …